Despite long covid's vast reach, the federal government's investment in researching the disease — to the tune of $1.15 billion as of December — has so far failed to bring any new treatments to market.
Geeta Sood, assistant professor of medicine and epidemiologist at Johns Hopkins Bayview Medical Center, tells Today.com. With COVID-19 in the mix, the dynamics of respiratory virus season have changed ...
With the acute phase of the Covid-19 pandemic fading even as the coronavirus ... that some who benefited said the improvement didn’t last. By Pam Belluck The preparers filed for pandemic ...
Nature asked the world’s largest health-research funders what they are doing to study a life stage experienced by half of humanity. Here is what some of them told us.